Hangzhou Alltest Biotech Co. Ltd. A (688606) - Total Liabilities

Latest as of March 2026: CN¥226.79 Million CNY ≈ $33.19 Million USD

Based on the latest financial reports, Hangzhou Alltest Biotech Co. Ltd. A (688606) has total liabilities worth CN¥226.79 Million CNY (≈ $33.19 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Hangzhou Alltest Biotech Co. Ltd. A equity growth rate to track the company's year-over-year net asset growth rate.

Hangzhou Alltest Biotech Co. Ltd. A - Total Liabilities Trend (2016–2025)

This chart illustrates how Hangzhou Alltest Biotech Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See Hangzhou Alltest Biotech Co. Ltd. A (688606) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Hangzhou Alltest Biotech Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Hangzhou Alltest Biotech Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Golden Bridge SHG:603918	China	CN¥319.78 Million
Community Healthcare Trust Inc NYSE:CHCT	USA	$588.75 Million
Cub Elecparts Inc TW:2231	Taiwan	NT$6.31 Billion
SEALSQ Corp NASDAQ:LAES	USA	$23.89 Million
Caregen Co.Ltd KQ:214370	Korea	₩17.10 Billion
Leon Technology Co Ltd SHE:300603	China	CN¥808.12 Million
Topkey Corp TW:4536	Taiwan	NT$4.78 Billion
AGI Greenpac Limited NSE:AGI	India	Rs11.47 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Hangzhou Alltest Biotech Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Hangzhou Alltest Biotech Co. Ltd. A worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	12.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Alltest Biotech Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)

The table below shows the annual total liabilities of Hangzhou Alltest Biotech Co. Ltd. A from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥296.09 Million ≈ $43.33 Million	-2.15%
2024-12-31	CN¥302.60 Million ≈ $44.28 Million	+6.36%
2023-12-31	CN¥284.50 Million ≈ $41.63 Million	-46.20%
2022-12-31	CN¥528.80 Million ≈ $77.38 Million	-28.03%
2021-12-31	CN¥734.71 Million ≈ $107.51 Million	+311.73%
2020-12-31	CN¥178.45 Million ≈ $26.11 Million	+354.04%
2019-12-31	CN¥39.30 Million ≈ $5.75 Million	-0.42%
2018-12-31	CN¥39.47 Million ≈ $5.78 Million	-24.05%
2017-12-31	CN¥51.97 Million ≈ $7.60 Million	+60.31%
2016-12-31	CN¥32.42 Million ≈ $4.74 Million	--

About Hangzhou Alltest Biotech Co. Ltd. A

SHG:688606 China Medical Instruments & Supplies

Market Cap

$496.65 Million

CN¥3.39 Billion CNY

Market Cap Rank

#12237 Global

#3525 in China

Share Price

CN¥42.81

Change (1 day)

-2.62%

52-Week Range

CN¥41.00 - CN¥77.67

All Time High

CN¥121.60